You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Vaccine against tuberculosis: what’s new?
|
|---|---|
| Published in |
BMC Infectious Diseases, January 2014
|
| DOI | 10.1186/1471-2334-14-s1-s2 |
| Pubmed ID | |
| Authors |
Carlotta Montagnani, Elena Chiappini, Luisa Galli, Maurizio de Martino |
| Abstract |
one of the World Health Organization Millennium Development Goal is to reduce tuberculosis incidence by 2015. However, more of 8.5 million tuberculosis cases have been reported in 2011, with an increase of multidrug-resistant strains. Therefore, the World Health Organization target cannot be reach without the help of a vaccine able to limit the spread of tuberculosis. Nowadays, bacille Calmette-Guérin is the only vaccine available against tuberculosis. It prevents against meningeal and disseminated tuberculosis in children, but its effectiveness against pulmonary form in adolescents and adults is argued. |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Nigeria | 1 | 17% |
| Netherlands | 1 | 17% |
| United Kingdom | 1 | 17% |
| Unknown | 3 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 6 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 132 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| India | 1 | <1% |
| Bangladesh | 1 | <1% |
| Argentina | 1 | <1% |
| Unknown | 128 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 27 | 20% |
| Student > Master | 26 | 20% |
| Researcher | 19 | 14% |
| Student > Ph. D. Student | 12 | 9% |
| Student > Postgraduate | 7 | 5% |
| Other | 18 | 14% |
| Unknown | 23 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 30 | 23% |
| Agricultural and Biological Sciences | 28 | 21% |
| Biochemistry, Genetics and Molecular Biology | 11 | 8% |
| Immunology and Microbiology | 10 | 8% |
| Nursing and Health Professions | 8 | 6% |
| Other | 17 | 13% |
| Unknown | 28 | 21% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 January 2014.
All research outputs
#6,896,314
of 23,124,001 outputs
Outputs from BMC Infectious Diseases
#2,175
of 7,757 outputs
Outputs of similar age
#81,575
of 306,507 outputs
Outputs of similar age from BMC Infectious Diseases
#43
of 137 outputs
Altmetric has tracked 23,124,001 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 7,757 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.3. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 306,507 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 137 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.